In May 2017, Nevro CEO Rami Elghandour chatted with Anne Staylor, BioMedGPS Managing Editor/Neuro Analyst to discuss dynamics in the global spinal cord stimulation (SCS) market, including trends, drivers, challenges, competition, and opportunity that would influence the Company’s growth. 

A fascinating read then, that now has us appraising a year later if Elghandour's expansion predictions came to pass. Is Nevro still the one to beat as the top leader in the neuromodulation field?

 or read the interview in full below!

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Spine Market Recap.

While we saw a slight upturn in the market in Q4, the beginning of 2018 has again revealed the Spine market’s true colors – with a slight decline in the overall market and notable pricing pressures. With -1.9% YoY growth, Stryker’s US Spine revenues were challenged by market softness as well as low-double digit (~10%) price declines across core product lines. K2M management reported ...

Among the many topics covered in the Q118 Spine Market Recap are:

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Hemostats and Sealants Market Recap.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Trauma Market Recap.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 US Surgical Matrices Market Recap.

Medtronic’s Stacey Pugh discusses the Company’s new Riptide Aspiration System, new products in development, and growth strategies for the neurovascular business in a podcast interview with SmartTRAK at the International Stroke Conference (ISC) 2018 held Jan. 24-26, 2018 in Los Angeles, CA.

Anne Staylor here with BioMedGPS. We're at the International Stroke Conference in Los Angeles, and today I'm talking with Stacey Pugh of Medtronic Neurovascular. Hi Stacey, thanks for joining me.

In the market for stroke devices, Europe seems to be the proving ground for next generation devices, and several companies with novel technologies are emerging from Europe that could potentially reach the US market in the next several years. One European company taking aim at the US market is Bochum, Germany-based phenox GmbH.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Extremities Market Recap.

The US Extremities Market experienced a slight dip in Q118, with sequential growth down from +8.4% to +6.9% that extended into all categories. While Q118 was relatively quiet, FDA clearances, new competitive products and new players in Shoulder, Ankles and Fixation should heat up the segment in 2018.

Among the many topics covered in the Q118 Extremities Market Recap are:

SmartTRAK is excited to be attending TOBI 2018 - The 9th Annual PRP & Regenerative Medicine Symposium, Workshops & Cadaver Labs - June 7-9 at Wynn, Las Vegas, Nevada.

SmartTRAK is excited to be attending LINNC Paris 2018 on June 11-13, 2018, at the Carrousel du Louvre, Paris, France.